{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:52:49Z","timestamp":1790981569515,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>We recently developed a simple novel index called fibrosis 6 (FIB-6) using machine learning data analysis. We aimed to evaluate its performance in the diagnosis of liver fibrosis and cirrhosis in chronic hepatitis B (CHB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective observational analysis of data was obtained from seven countries (Egypt, Kingdom of Saudi Arabia (KSA), Turkey, Greece, Oman, Qatar, and Jordan) of CHB patients. The inclusion criteria were receiving an adequate liver biopsy and a complete biochemical and hematological data. The diagnostic performance analysis of the FIB-6 index was conducted and compared with other non-invasive scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 603 patients were included for the analysis; the area under the receiver operating characteristic curve (AUROC) of FIB-6 for the discrimination of patients with cirrhosis (F4), compensated advanced chronic liver disease (cACLD) (F3 and F4), and significant fibrosis (F2\u2013F4) was 0.854, 0.812, and 0.745, respectively. The analysis using the optimal cut-offs of FIB-6 showed a sensitivity of 70.9%, specificity of 84.1%, positive predictive value (PPV) of 40.3%, and negative predictive value (NPV) of 95.0% for the diagnosis of cirrhosis. For the diagnosis of cACLD, the results were 71.5%, 69.3%, 40.8%, and 89.2%, respectively, while for the diagnosis of significant fibrosis, the results were 68.3%, 67.5%, 59.9%, and 75.0%, respectively. When compared to those of fibrosis 4 (FIB-4) index, aspartate aminotransferase (AST)-to-platelet ratio index (APRI), and AST-to-alanine aminotransferase (ALT) ratio (AAR), the AUROC for the performance of FIB-6 was higher than that of FIB-4, APRI, and AAR in all fibrosis stages. FIB-6 gave the highest sensitivity and NPV (89.1% and 92.4%) in ruling out cACLD and cirrhosis, as compared to FIB-4 (63.8% and 83.0%), APRI (53.9% and 86.6%), and AAR (47.5% and 82.3%), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The FIB-6 index could be used in ruling out cACLD, fibrosis, and cirrhosis with good reliability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_27_24","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T05:03:48Z","timestamp":1710392628000},"page":"138-144","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Validation of FIB-6 score in assessment of liver fibrosis in chronic hepatitis B"],"prefix":"10.4103","volume":"30","author":[{"given":"Khalid","family":"Alswat","sequence":"first","affiliation":[{"name":"Liver Disease Research Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham","family":"Soliman","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Egyptian Liver Research Institute and Hospital (ELRIAH), Sherbin, ElMansoura, Egypt"},{"name":"Tropical Medicine Department, Faculty of Medicine, Port Said University, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabiel N. H.","family":"Mikhail","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Egyptian Liver Research Institute and Hospital (ELRIAH), Sherbin, ElMansoura, Egypt"},{"name":"Biostatistics and Cancer Epidemiology Department, South Egypt Cancer Institute, Assiut University, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necati","family":"\u00d6rmeci","sequence":"additional","affiliation":[{"name":"Istanbul Health and Technology University, Department of Gastroenterohepatology, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Dalekos","sequence":"additional","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moutaz F. M.","family":"Derbala","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Hamad Hospital, Doha, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said Ahmed","family":"Al-Busafi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Hamoudi","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Al-Bashir Hospital, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Shiha","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department, Egyptian Liver Research Institute and Hospital (ELRIAH), Sherbin, ElMansoura, Egypt"},{"name":"Hepatology and Gastroenterology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"10395","DOI":"10.3748\/wjg.v20.i30.10395","article-title":"Natural history of chronic hepatitis B: Phases in a complex relationship","volume":"20","author":"Croagh","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"40","DOI":"10.21037\/atm.2017.01.28","article-title":"Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection","volume":"5","author":"Parikh","year":"2017","journal-title":"Ann Transl Med"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic hepatitis B infection: A review","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","article-title":"Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology","volume":"69","author":"Neuberger","year":"2020","journal-title":"Gut"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatolology"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"R8-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"R9-20240829","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/17474124.2019.1579641","article-title":"Non-invasive assessment of liver fibrosis and prognosis: An update on serum and elastography markers","volume":"13","author":"Agbim","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis","volume":"61","author":"Xiao","year":"2015","journal-title":"Hepatology"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","article-title":"Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients","volume":"64","author":"Kim","year":"2016","journal-title":"J Hepatol"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"100067","DOI":"10.1016\/j.jhepr.2020.100067","article-title":"Limitations of non-invasive tests for assessment of liver fibrosis","volume":"2","author":"Patel","year":"2020","journal-title":"JHEP Rep"},{"issue":"Suppl 1","key":"R13-20240829","first-page":"91","article-title":"Hepatitis B: Are non-invasive markers of liver fibrosis reliable?","volume":"34","author":"Castera","year":"2014","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"R14-20240829","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/hepr.13729","article-title":"Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C","volume":"52","author":"Shiha","year":"2022","journal-title":"Hepatol Res"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","article-title":"Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: A 2016 update","volume":"11","author":"Shiha","year":"2017","journal-title":"Hepatol Int"},{"key":"R16-20240829","first-page":"15","article-title":"The French METAVIR Cooperative Study Group","volume":"20","year":"1994","journal-title":"Hepatology"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0016-5085(88)80022-2","article-title":"Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis","volume":"95","author":"Williams","year":"1988","journal-title":"Gastroenterology"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"e105728","DOI":"10.1371\/journal.pone.0105728","article-title":"The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: A meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"R21-20240829","doi-asserted-by":"crossref","first-page":"8074837","DOI":"10.1155\/2022\/8074837","article-title":"Prevalence of obesity and overweight among adults in the middle east countries from 2000 to 2020: A systematic review and meta-analysis","volume":"2022","author":"Okati-Aliabad","year":"2022","journal-title":"J Obes"},{"key":"R22-20240829","doi-asserted-by":"crossref","first-page":"521","DOI":"10.12998\/wjcc.v6.i12.521","article-title":"Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B","volume":"6","author":"Wang","year":"2018","journal-title":"World J Clin Cases"},{"key":"R23-20240829","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.3748\/wjg.14.6154","article-title":"Liver stiffness in the hepatitis B virus carrier: A non-invasive marker of liver disease influenced by the pattern of transaminases","volume":"14","author":"Oliveri","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R24-20240829","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ajg.2014.21","article-title":"FibroTest\/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: A meta-analysis","volume":"109","author":"Salkic","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R25-20240829","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/his.12957","article-title":"Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: Implications for liver biopsy interpretation","volume":"68","author":"Quaglia","year":"2016","journal-title":"Histopathology"},{"key":"R26-20240829","doi-asserted-by":"crossref","first-page":"e6336","DOI":"10.1097\/MD.0000000000006336","article-title":"Evaluation of APRI and FIB-4 for non-invasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT \u2264 2 ULN: A retrospective cohort study","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_27_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:27:01Z","timestamp":1787768821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_27_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_27_24","relation":{},"ISSN":["1319-3767","1998-4049"],"issn-type":[{"value":"1319-3767","type":"print"},{"value":"1998-4049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"2024-01-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}